Perioperative complications and surgical oncology outcomes in an initial study from 84 patients submitted to laparoscopic radical cystectomy.

OBJECTIVES: The Gold Standard treatment for a non-metastatic, invasive bladder cancer is an open radical cystoprostatectomy (ORCP). Laparoscopic radical cystoprostatectomy (LRCP) is still an experimental technique in evaluation. We describe our perioperative results defined as surgical and safety oncology variables. METHODS: Every patient who underwent a LRCP between January 2007 and July 2011 in the urology department of the University Public Hospital was evaluated. We perform a descriptive retrospective analysis. RESULTS: We evaluated 84 patients, 72 males and 12 females, with a mean age of 68 (44-79). A Bricker diversion was performed in 80 patients, a Camey II bladder replacement was performed in 3 patients, and a Studer bladder replacement was performed in 1 patient. Seventeen patients (20.23%) presented with previous abdominal surgery, and 6 patients (7.14%) presented a medical history of urological surgery. The mean surgery time was 257.57 minutes (180-420). The mean hospital stay was 11.875 days (standard deviation (SD): 6.28). The onset of tolerance to surgery occurred after 3.7 days (SD: 2.21).The transfusion rate after surgical intervention was 20.2%. The mean number of nodes removed, by means of ilio-obturator lymphadenectomy, was 17 (13-19). There were no intraoperative complications. Early complications (less than 1 month after the intervention) occurred in 28 patients (33.3% ).There were no post-operative deaths. There were late complications (starting one month after the intervention) in 7 patients (8.3% ). CONCLUSIONS: Our study demonstrated that LRCP is safe and reproducible and represents a minimally invasive option for patients with infiltrative bladder cancer.

Complicaciones perioperatorias y resultados oncológicos quirúrgicos en una serie inicial de 84 pacientes sometidos a cistectomía radical laparoscópica / Perioperative complications and surgical oncology outcomes in an initial study from 84 patients submitted to laparoscopic radical cystectomy

OBJETIVO: La cistectomía radical abierta es el estándar oro para el tratamiento del cáncer vesical infiltrante. La cistectomía radical laparoscópica (CPRL) continúa siendo una técnica experimental en evaluación. Describimos nuestros resultados perioperatorios definidos como complicaciones quirúrgicas y variables de seguridad oncológica. MÉTODOS: Revisión retrospectiva de una base de datos de cumplimentación retrospectiva de pacientes intervenidos con CRPL en el periodo comprendido entre enero del 2007 hasta julio del 2011 en un Hospital Universitario público. RESULTADOS: Fueron intervenidos 84 pacientes (72 varones y 12 mujeres), con una edad media de 68 años (44 –79). En 80 pacientes se realizó derivación tipo Bricker, en 3 sustitución vesical tipo Camey II, y en 1 sustitución vesical tipo Studer, de manera extracorpórea en todos ellos. 17 Pacientes (20,23%) presentaban cirugía abdominal previa y 6 (7,14%) presentaban antecedentes de cirugía urológica previa. El tiempo operatorio medio fue de 257,57 minutos (180-420 minutos). El tiempo medio de la estancia hospitalaria fue de 11,875 días (desviación estándar (DE): 6,28). El inicio de la tolerancia fue al 3,7 días (DE: 2,21). La tasa de transfusión posterior a la intervención quirúrgica fue del 20,2%. La mediana de ganglios extirpados, mediante linfadenectomía ilio-obturatriz bilateral, fue de 17 (13-19).No se registraron complicaciones intraoperatorias. 28 pacientes (33,3%) desarrollaron complicaciones en el postoperatorio temprano (primer mes), sin registrarse ningún fallecimiento. 7 Pacientes (8,3%) presentaron complicaciones tardías (a partir del mes de la cirugía). CONCLUSIONES: Nuestra serie pone de manifiesto que la técnica de CPRL es segura y reproducible, por lo que se trata de una alternativa mínimamente invasiva para los pacientes con cáncer vesical infiltrante (AU)

OBJECTIVES: The gold standard treatment for a non-metastatic, invasive bladder cancer is an open radical cystoprostatectomy (ORCP). Laparoscopic radical cystoprostatectomy (LRCP) continues being an experimental technique in evaluation. We describe our perioperative results defined as surgical complications and oncologic safety variables. METHODS: From January 2007 to July 2011, all patients undergoing laparoscopic radical cystoprostatectomy (LRCP) in the Urology Department of a public University Hospital were evaluated. We perform a descriptive retrospective analysis. RESULTS: We evaluated 84 patients, 72 males and 12 females, with a mean age of 68 years (44-79). A Bricker urinary diversion was performed in 80 patients, a Camey II bladder replacement was performed in 3 patients, and a Studer bladder replacement was performed in 1 patient. Seventeen patients (20.23%) presented with past medical history of abdominal surgery, and 6 patients (7.14%) history of urological surgery. The mean operative time was 257.57 minutes (180-420). Mean hospital stay was 11.875 days (standard deviation (SD): 6.28). The onset of oral tolerance occurred at 3.7 days (SD: 2.21). The transfusion rate after surgical intervention was 20.2%. The mean number of nodes removed, by means of iliac-obturator lymph node dissection, was 17 (13-19). There were no intraoperative complications. Complications occurred in 28 patients (33.3%) as early complications (less than 1 month after the intervention). There were no post-operative deaths. There were late complications (starting one month after the intervention) in 7 patients (8.3%). CONCLUSIONS: Our study demonstrated that LRCP is safe and reproducible and represents a minimally invasive option for patients with infiltrative bladder cancer (AU)